# Title
Alternative O
splicing O
in O
the O
alpha-galactosidase B-Gene
A I-Gene
gene: O
increased O
exon O
inclusion O
results O
in O
the O
Fabry B-Disease
cardiac I-Disease
phenotype. I-Disease

# Abstract
Fabry B-Disease
disease I-Disease
is O
an O
inborn B-Disease
error I-Disease
of I-Disease
glycosphingolipid I-Disease
catabolism, O
resulting O
from O
deficient O
activity O
of O
lysosomal O
alpha-galactosidase B-Gene
A I-Gene
(alpha-Gal B-Gene
A). I-Gene
A O
rare O
alternative O
splicing O
that O
introduces O
a O
57-nucleotide O
(nt) O
intronic O
sequence O
to O
the O
alpha-Gal B-Gene
A I-Gene
transcript O
from O
intron O
4 O
of O
the O
gene O
has O
been O
identified. O
In O
addition, O
a O
novel O
midintronic O
base O
substitution O
that O
results O
in O
substantially O
increased O
alternative O
splicing O
has O
been O
identified O
in O
a O
patient B-Species
with O
Fabry B-Disease
disease I-Disease
who O
has O
the O
cardiac O
variant O
phenotype. O
The O
sequence O
of O
the O
patient's B-Species
intron O
4 O
contains O
a O
single O
G-->A B-DNAMutation
transversion O
at O
genomic O
nt O
9331 O
(IVS4+919 O
G-->A B-DNAMutation
), O
located O
at O
the O
minus O
sign4 O
position O
of O
the O
3' O
end O
of O
the O
intronic O
insertion O
(nts O
9278--9334 O
in O
the O
genomic O
sequence). O
Minigene O
constructs O
containing O
the O
entire O
intron O
4 O
sequence O
with O
G, O
A, O
C, O
or B-Disease
T I-Disease
at I-DNAMutation
nt I-DNAMutation
9331 I-DNAMutation
within O
an O
alpha-Gal B-Gene
A I-Gene
complementary O
DNA O
expression O
vector O
were O
prepared O
and O
expressed O
in O
COS-1 B-CellLine
cells. O
Whereas O
transfection O
of O
the O
G O
or B-Disease
T I-Disease
minigenes O
transcribed O
predominantly O
normal-sized O
transcripts, O
the O
transfection O
of O
the O
A O
or O
C O
minigenes O
produced O
a O
large O
amount O
of O
the O
alternatively O
spliced O
transcript. O
These O
results O
suggest O
that O
the O
G-->A B-DNAMutation
mutation, O
within O
an O
A O
C-rich O
domain, O
results O
in O
increased O
recognition O
of O
the O
alternative O
splicing O
by O
an O
A O
C-rich O
enhancer-type O
exonic O
splicing O
enhancer. O
The O
intronic O
mutation O
was O
not O
observed O
in O
100 O
unrelated O
unaffected O
men B-Species
but O
was O
present O
in O
6 O
unrelated O
patients B-Species
with O
cardiac B-Disease
Fabry B-Disease
disease. I-Disease
Reverse-transcriptase O
polymerase O
chain O
reaction O
of O
total O
RNA O
of O
various O
normal O
human B-Species
tissues O
revealed O
that O
the O
alternatively O
spliced O
transcript O
was O
present O
in O
all O
of O
the O
samples, O
and O
especially O
at O
a O
higher O
ratio O
in O
the O
lung O
and O
muscle. O
The O
normal O
transcript O
was O
present O
in O
the O
patients' B-Species
lymphoblasts O
and O
resulted O
in O
approximately O
10% O
residual O
enzyme O
activity, O
leading O
to O
a O
cardiac O
phenotype O
of O
Fabry B-Disease
disease. I-Disease